You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: β-agonists plus ipratropium bromide improve airflow obstruction in adults with acute asthma

https://doi.org/10.1136/ebm.5.1.16

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (1999) Ann Emerg Med 34, 8. Stoodley RG, Aaron SD, Dales RE.. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials.. Jul;. :. –18.
    OpenUrlCrossRefPubMedWeb of Science

    
 
 QUESTION: Is the addition of inhaled ipratropium bromide to β-agonist therapy effective in the emergency treatment of adults with acute asthma?

    Data sources

    Studies were identified by searching Medline (1966 to January 1997), EMBASE/Excerpta Medica (1980–97), CINAHL (1982 to 1997), Biological Abstracts on CD (1990 to 1997), the Cochrane Library, Current Contents (1996 to August 1997), and bibliographies of relevant papers and by contacting the manufacturer of ipratropium.

    Study selection

    Published and unpublished studies in English, French, and Italian were selected if they were randomised, placebo-controlled trials that assessed the use of ipratropium in addition to β-agonists (administered by inhaler or wet nebuliser) compared with β-agonist therapy alone in adult patients with acute asthma presenting to a hospital emergency department (ED) …

    View Full Text

    Footnotes

    • Source of funding: no external funding.

    • For correspondence: Dr S D Aaron, Ottawa General Hospital, Room LM-17, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada. FAX 613-737-8141.

    • ↵* Data provided by author.